Evaluation of the effect of pentoxifylline on erythropoietin-resistant anemia in hemodialysis patients.

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia

Volumn 25, Issue 1, 2014, Pages 73-78

  Mohammadpour, Amir Hooshang ^b   Nazemian, Fatemeh ^a   Khaiat, Mohammad Hassanzade ^b   Tafaghodi, Mohsen ^b   Salari, Pooneh ^b   Charkazi, Somaieh ^b   Naghibi, Masih ^b   Shamsara, Jamal ^b  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; BIOLOGICAL MARKER; ERYTHROPOIETIN; HEMOGLOBIN; PENTOXIFYLLINE; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANEMIA; ARTICLE; BLOOD; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; DRUG EFFECT; DRUG RESISTANCE; DRUG SUBSTITUTION; ERYTHROPOIESIS; FEMALE; HUMAN; IRAN; MALE; METABOLISM; MIDDLE AGED; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY; TIME; TREATMENT FAILURE; UPREGULATION;

ADULT; ANEMIA; BIOLOGICAL MARKERS; DRUG RESISTANCE; DRUG SUBSTITUTION; ERYTHROPOIESIS; ERYTHROPOIETIN; FEMALE; HEMATINICS; HEMOGLOBINS; HUMANS; IRAN; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PENTOXIFYLLINE; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; RENAL DIALYSIS; TIME FACTORS; TREATMENT FAILURE; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84894674555     PISSN: 13192442     EISSN: None     Source Type: None    
DOI: 10.4103/1319-2442.124492     Document Type: Article

References (0)